{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:24:46Z","timestamp":1782602686190,"version":"3.54.5"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,8,15]]},"DOI":"10.2169\/internalmedicine.1662-18","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:15:08Z","timestamp":1558476908000},"page":"2387-2391","source":"Crossref","is-referenced-by-count":7,"title":["Acute Promyelocytic Leukemia and HIV: Case Reports and a Review of the Literature"],"prefix":"10.2169","volume":"58","author":[{"given":"Akane","family":"Kunitomi","sequence":"first","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"lmamura","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Immunology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Yokomaku","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Immunology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroatsu","family":"Iida","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Little RF, Dunleavy K. Update on the treatment of HIV-associated hematologic malignancies. Hematology Am Soc Hematol Educ Program 2013: 382-388, 2013.","DOI":"10.1182\/asheducation-2013.1.382"},{"key":"2","unstructured":"2. Rios A. HIV-related hematological malignancies: a concise review. Clin Lymphoma Myeloma Leuk 14 (Suppl): S96-S103, 2014."},{"key":"3","unstructured":"3. Fauci AS, Folkers GK, Lane HC. Human Immunodeficiency Virus Disease: AIDS and Related Disorders. In: Harrison&apos;s Principals of Internal Medicine. 20th ed. Kasper DL, Fauci AS, Hauser SL, et al., Eds. McGraw-Hill Education, New York, 2018: 1432-1502."},{"key":"4","unstructured":"4. Sutton L, Gu\u00e9nel P, Tanguy ML, et al.; French Study Group on Acute Myeloid Leukaemia in HIV-Infected Patients. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol 112: 900-908, 2001."},{"key":"5","unstructured":"5. Drilon AD, Gamboa EO, Koolaee R, Goel A. Acute promyelocytic leukemia in HIV-infected adults: a case report and review of therapeutic considerations. Clin Lymphoma Myeloma Leuk 10: E47-E52, 2010."},{"key":"6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00002030-200204120-00006","volume":"16","author":"DM Aboulafia","year":"2002","unstructured":"6. Aboulafia DM, Meneses M, Ginsberg S, Siegel MS, Howard WW, Dezube BJ. Acute myeloid leukemia in patients infected with HIV-1. AIDS 16: 865-876, 2002.","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Watts JM, Tallman MS. Acute promyelocytic leukemia: what is the new standard of care? Blood Rev 28: 205-212, 2014.","DOI":"10.1016\/j.blre.2014.07.001"},{"key":"8","unstructured":"8. Lancet JE, Maslak P, Soignet SL. Acute promyelocytic leukemia. In: Wintrobe&apos;s Clinical Hematology. 13th ed. Greer JP, Arber DA, Glader B, et al., Eds. Lippincott Williams and Wilkins, Philadelphia, 2014: 1656-1672."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Sanz MA, Mart\u00edn G, Gonz\u00e1lez M, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood 103: 1237-1243, 2004.","DOI":"10.1182\/blood-2003-07-2462"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Elliot E, Chirwa M, Boffito M. How recent findings on the pharmacokinetics and pharmacodynamics of integrase inhibitors can inform clinical use. Curr Opin Infect Dis 30: 58-73, 2017.","DOI":"10.1097\/QCO.0000000000000327"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Sanz MA, Montesinos P, Ray\u00f3n C, et al.; PETHEMA and HOVON Groups. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood 115: 5137-5146, 2010.","DOI":"10.1182\/blood-2010-01-266007"},{"key":"12","unstructured":"12. Seaberg EC, Wiley D, Mart\u00ednez-Maza O, et al. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 116: 5507-5516, 2010."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Calvo R, Ribera JM, Battle M, et al. Acute promyelocytic leukemia in a HIV seropositive patient. Leuk Lymphoma 26: 621-624, 1997.","DOI":"10.3109\/10428199709050899"},{"key":"14","unstructured":"14. Gatphoh ED, Zamzachin G, Devi SB, Punyabati P. AIDS related malignant disease at regional institute of medical sciences. Indian J Pathol Microbiol 44: 1-4, 2001."},{"key":"15","unstructured":"15. Kudva GC, Maliekel K, Richart JM, et al. Acute promyelocytic leukemia and HIV-1 infection: case report and review of the literature. Am J Hematol 77: 287-290, 2004."},{"key":"16","unstructured":"16. De Vita S, De Matteis S, Laurenti L, et al. Acute promyelocytic leukemia in an HIV-infected patient: a case report. Am J Hematol 81: 300, 2006."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Boban A, Radman I, Zadro R, et al. Acute promyelocytic leukemia after whole brain irradiation of primary brain lymphoma in an HIV-infected patient. Eur J Med Res 14: 42-43, 2009.","DOI":"10.1186\/2047-783X-14-1-42"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wang ZY, Chen Z. Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia. Lancet Oncol 1: 101-106, 2000.","DOI":"10.1016\/S1470-2045(00)00017-6"},{"key":"19","unstructured":"19. Mathews V, George B, Lakshmi KM, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood 107: 2627-2632, 2006."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369: 111-121, 2013.","DOI":"10.1056\/NEJMoa1300874"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Torres HA, Mulanovich V. Management of HIV infection in patients with cancer receiving chemotherapy. Clin Infect Dis 59: 106-114, 2014.","DOI":"10.1093\/cid\/ciu174"},{"key":"22","unstructured":"22. Shi X, Sims MD, Hanna MM, et al. Neutropenia during HIV infection: adverse consequences and remedies. Int Rev Immunol 33: 511-536, 2014."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/16\/58_1662-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T10:45:30Z","timestamp":1663497930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/16\/58_1662-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":22,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1662-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]}}}